Literature DB >> 16751407

Local amplification of glucocorticoids by 11 beta-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes.

James S Gilmour1, Agnes E Coutinho, Jean-François Cailhier, Tak Yung Man, Michael Clay, Graham Thomas, Hayley J Harris, John J Mullins, Jonathan R Seckl, John S Savill, Karen E Chapman.   

Abstract

Glucocorticoids promote macrophage phagocytosis of leukocytes undergoing apoptosis. Prereceptor metabolism of glucocorticoids by 11beta-hydroxysteroid dehydrogenases (11beta-HSDs) modulates cellular steroid action. 11beta-HSD type 1 amplifies intracellular levels of active glucocorticoids in mice by reactivating corticosterone from inert 11-dehydrocorticosterone in cells expressing the enzyme. In this study we describe the rapid (within 3 h) induction of 11beta-HSD activity in cells elicited in the peritoneum by a single thioglycolate injection in mice. Levels remained high in peritoneal cells until resolution. In vitro experiments on mouse macrophages demonstrated that treatment with inert 11-dehydrocorticosterone for 24 h increased phagocytosis of apoptotic neutrophils to the same extent as corticosterone. This effect was dependent upon 11beta-HSD1, as 11beta-HSD1 mRNA, but not 11beta-HSD2 mRNA, was expressed in these cells; 11-dehydrocorticosterone was ineffective in promoting phagocytosis by Hsd11b1(-/-) macrophages, and carbenoxolone, an 11beta-HSD inhibitor, prevented the increase in phagocytosis elicited in wild-type macrophages by 11-dehydrocorticosterone. Importantly, as experimental peritonitis progressed, clearance of apoptotic neutrophils was delayed in Hsd11b1(-/-) mice. These data point to an early role for 11beta-HSD1 in promoting the rapid clearance of apoptotic cells during the resolution of inflammation and indicate a novel target for therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16751407     DOI: 10.4049/jimmunol.176.12.7605

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Glucocorticoids exert opposing effects on macrophage function dependent on their concentration.

Authors:  Hee-Young Lim; Nora Müller; Marco J Herold; Jens van den Brandt; Holger M Reichardt
Journal:  Immunology       Date:  2007-04-23       Impact factor: 7.397

Review 2.  11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function.

Authors:  Karen E Chapman; Jonathan R Seckl
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

Review 3.  Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease.

Authors:  Nicholas C Bene; Pilar Alcaide; Henry H Wortis; Iris Z Jaffe
Journal:  Steroids       Date:  2014-04-21       Impact factor: 2.668

4.  Peroxisome proliferator-activated receptor-γ activation induces 11β-hydroxysteroid dehydrogenase type 1 activity in human alternative macrophages.

Authors:  Giulia Chinetti-Gbaguidi; Mohamed Amine Bouhlel; Corinne Copin; Christian Duhem; Bruno Derudas; Bernadette Neve; Benoit Noel; Jerome Eeckhoute; Philippe Lefebvre; Jonathan R Seckl; Bart Staels
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12-29       Impact factor: 8.311

5.  Improved heart function follows enhanced inflammatory cell recruitment and angiogenesis in 11betaHSD1-deficient mice post-MI.

Authors:  Sara J McSweeney; Patrick W F Hadoke; Agnieszka M Kozak; Gary R Small; Hiba Khaled; Brian R Walker; Gillian A Gray
Journal:  Cardiovasc Res       Date:  2010-05-21       Impact factor: 10.787

Review 6.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 7.  Neuroendocrine-immune interactions in rheumatoid arthritis: mechanisms of glucocorticoid resistance.

Authors:  Marni N Silverman; Esther M Sternberg
Journal:  Neuroimmunomodulation       Date:  2008-07-29       Impact factor: 2.492

8.  Obesity impairs apoptotic cell clearance in asthma.

Authors:  Ruby Fernandez-Boyanapalli; Elena Goleva; Christena Kolakowski; Elysia Min; Brian Day; Donald Y M Leung; David W H Riches; Donna L Bratton; E Rand Sutherland
Journal:  J Allergy Clin Immunol       Date:  2012-11-13       Impact factor: 10.793

9.  Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta.

Authors:  Shuji Sai; Cristina L Esteves; Val Kelly; Zoi Michailidou; Karen Anderson; Anthony P Coll; Yuichi Nakagawa; Takehiko Ohzeki; Jonathan R Seckl; Karen E Chapman
Journal:  Mol Endocrinol       Date:  2008-07-10

Review 10.  Annexin A1 and glucocorticoids as effectors of the resolution of inflammation.

Authors:  Mauro Perretti; Fulvio D'Acquisto
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.